FDA Adverse Event Injury Summary report: N

VNS THERAPY LEAD

MDR report key: 526050 · Received May 20, 2004

Report

Report Number
1644487-2004-00462
Event Type
Injury
Date Received
May 20, 2004
Date of Event
March 2, 2004
Report Date
April 8, 2004
Manufacturer
CYBERONICS, INC.
Product Code
LYJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

REPORTER INDICATED THAT PT WAS EXPERIENCING BOTHERSOME HOARSENESS AND TROUBLE SWALLOWING AFTER VNS IMPLANT. STIMULATION WAS INITIATED TWO WEEKS AFTER IMPLANT. STIMULATION WAS INITIATED TWO WEEKS AFTER IMPLANT. LARYNGOSCOPY REVEALED THAT THE PT'S RIGHT VOCAL CORD WAS NOT WORKING. TREATING NEUROLOGIST INDICATED THAT THE EVENT WAS RELATED TO THE VNS. FURTHER FOLLOW-UP REVEALED THAT THE PT WAS DOING BETTER, ONLY COUGHING OCCASIONALLY AND THAT THEIR VOICE HAD ALMOST RETURNED BACK TO NORMAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VNS THERAPY LEAD BIPOLAR LEAD LYJ CYBERONICS, INC. 302-20 9597

Patients

Seq Age Sex Outcome Treatment
1 27 YR Disability MODEL 102 VNS THERAPY PULSE, EXPIR DATE 10/31/2005| DATE OF MFG 11/18/2003, STERILIZATION LOT# 9597.